Presented Research
Research conducted by the HIV Prevention Trials Network is often disseminated through various channels, including scientific journals, conferences, and other publications. During a study, HPTN investigators collaborate with funders, community leaders, and other stakeholders to develop comprehensive dissemination plans to inform the public and scientific community of research findings. Recent conferences and presented research are listed on this page.
HPTN at AIDS 2026
HPTN investigators and other colleagues dedicated to ending HIV globally met at the 26th International AIDS Conference (IAS) in Rio de Janeiro, Brazil and virtually from 26-31 July, 2026. Research from four HPTN studies was presented across five abstracts at this year’s conference.
Prevalence and associated factors for stigma related to pre-exposure prophylaxis use in South Africa and Thailand: HPTN 067 study (poster)
Patricia Fadzayi Mandima
2024-2025 HPTN Scholar
Learn more about HPTN 067
Estimating counterfactual background HIV incidence and cabotegravir efficacy versus a counterfactual placebo in HPTN 083 using Bayesian modeling (poster)
Elizabeth Brown
HPTN SDMC Co-Principal Investigator
Multilevel social influences on PrEP modality choice and adherence among a subset of persons enrolled in HPTN 083, an international injectable PrEP trial (oral)
Christina Psaros
HPTN 083 Protocol Team Member
Learn more about HPTN 083
Acceptability of peer-delivered systems navigation for HIV pre-exposure prophylaxis among heterosexual men and other key-informants in Malawi – results from HPTN 112 (poster)
Mina Hosseinipour
HPTN 112 (Njira) Protocol Member
Learn more about HPTN 112
Developing mobile Health tools to support PrEP uptake and persistence in persons male sex who have sex with men in the Americas (poster)
Susan Buchbinder
HPTN 113 (Duo) Protocol Chair
Learn more about HPTN 113
HPTN at CROI 2026
Researchers from the HPTN presented 7 posters at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) from 22-25 February 2026 in Denver, Colorado. Poster topics covered several areas to inform the scientific community on the latest data available, including novel interventions, the effectiveness of injectable PrEP, HIV testing, and PrEP use, retention, and persistence.
Modeled Effectiveness of CAB-LA Prioritization Strategies Based on Data From HPTN 083
Stansfield, S. E., Moore, M., Donnell, D., Hanscom, B., Landovitz, R. J., Marzinke, M. A., Scott, H., Boily, M.-C., Grinsztejn, B., McCauley, M., Rinehart, A., Rooney, J. F., & Dimitrov, D.
Cost-Effectiveness of HIV Monitoring for Long-Acting Cabotegravir Preexposure Prophylaxis in the US (HPTN 083)
Chi, K. K., Narasimhadevara, M., Grinsztejn, B., Flanagan, C. F., McCauley, M., Talbot, V. R., Freedberg, K. A., Weinstein, M. C., Paltiel, A. D., Landovitz, R. J., & Neilan, A. M.
Learn more about HPTN 083
Assessment of Total and Unbound Cabotegravir Pharmacokinetics Among Pregnant Women in HPTN 084
Marzinke, M. A., Voldal, E., Guo, X., Parsons, T. L., Piwowar-Manning, E., Agyei, Y., Hanscom, B., Rose, S., Ford, S. L., Rinehart, A. R., Rooney, J., Soto-Torres, L., Cohen, M. S., Hosseinipour, M., & Delany-Moretlwe, S., on behalf of the HPTN 084 Study Team.
Learn more about HPTN 084
HIV Rebound and Immune Dynamics at ATI Differ by Global Region and Control Status (HVTN 805/HPTN 093/A5390 & HVTN 804/HPTN 095/A539)
Karuna, S. T., Yu, P., Mkhize, N., De Rosa, S., Yssel, A., Gallardo-Cartagena, J., Laher, F., Andrew, P., Villaran, M., Mgodi, N., Sanchez, J., Montefiori, D., Williamson, C., DeCamp, A., & Bar, K., on behalf of the HVTN 805/HPTN 093/A5393 and HVTN 804/HPTN 095/A5390 AMP ATI Study Teams.
Feasibility and Acceptability of a Barbershop-Based HIV Intervention for Ugandan Men (HPTN 111)
Lukyamuzi, Z., Voldal, E., Agravat, D., Harris-Wisecarver, J., Maena, J., Scoville, C. W., Etima, J., Albano, M., Dyer, M., Piwowar-Manning, E., Nakabiito, C., Mujugira, A., Spiegel, H., Mirembe, B. G., & Donnell, D.
Perspectives and Interest in Long-Acting PrEP Among Men in Kalangala District, Uganda (HPTN 111)
Mirembe, B. G., Voldal, E., Agravat, D., Harris-Wisecarver, J., Maena, J., Rukundo, I., Ssemere, H., Nakalega, R., Albano, M., Nakabiito, C., Mujugira, A., Spiegel, H., Donnell, D., & Lukyamuzi, Z., on behalf of the HPTN 111 Study Team.
Learn more about HPTN 111
PrEP Engagement and Persistence Among Heterosexual Men in Malawi: Findings from HPTN 112
Rutstein, S. E., Mukatipa, M., Limarzi-Klyn, L., Chen, J., Marzinke, M., Agyei, Y., Voldal, E., Ye, T., Haines, D., Hamilton, E., Mkala, Y., Hosseinipour, M., Hoffman, I., Cohen, M., & Matoga, M.
Learn more about HPTN 112
Past Presentations
CROI 2025
See More
HIV Glasgow 2022
See More
CROI 2022 (Virtual)
See More
IAS 2021 (Virtual)
See More
CROI 2021 (Virtual)
See More
AIDS 2020 (Virtual)
See More
CROI 2020
See More